EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart

Parham Diba iD, Peter R Levasseur, Samuel D Newton iD, Khia Min Sabrina Koh, Paige C Arneson-Wissink iD, Xinxia Zhu iD, Peter Pham, Heike Mendez, Luke Whitcomb, Ariana Sattler, William R Woodward, Beth A Habecker iD and 2 more

The Journal of Physiology · 2026

DOI: 10.1113/jp290616 ↗

At a glance

Journal article in The Journal of Physiology, 2026. Written by Parham Diba and 13 co-authors. Institution: Medical Scientist Training Program, Oregon Health and Science University, Portland, Oregon, USA. Major MEDLINE topics: Cachexia, Pancreatic Neoplasms, Receptors, Adrenergic, beta-1, Heart. 56 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCATS NIH HHS, NHLBI NIH HHS, NCI NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cancer cachexia is a metabolic syndrome commonly observed in patients with pancreatic ductal adenocarcinoma (PDAC), characterized by wasting of skeletal and cardiac muscle. This condition is associated with the neurohormonal stress response and activation of the sympathetic nervous system. However the impact of cachexia on cardiac adrenergic signalling remains poorly understood. Here we used a preclinical model of PDAC cachexia to investigate how sympathetic input to the heart is altered. We found desensitization of β1‐adrenergic receptor (β1‐AR) in the heart, along with evidence of increased adrenergic tone. Pharmacological blockade with the β1‐selective antagonist metoprolol partially restored adrenergic responsiveness in PDAC mice, suggesting that elevated adrenergic drive contributes to β1‐AR desensitization. The impaired β1‐AR sensitivity blunted the chronotropic response to dobutamine and reduced inotropic reserve under adrenergic stress. Together these findings uncover disruption of cardiac adrenergic signalling in PDAC cachexia. image Key points Pancreatic cancer‐associated cachexia promotes β1‐adrenergic receptor desensitization in the heart. Pancreatic cancer‐induced β1‐adrenergic receptor desensitization is partly mediated by increased adrenergic transmission to the heart. β1‐adrenergic receptor desensitization in mice with pancreatic cancer reduces contractile reserve under adrenergic stress.

Subjects

MeSH terms (MEDLINE)

CachexiaPancreatic NeoplasmsReceptors, Adrenergic, beta-1HeartAnimalsMiceMaleSignal TransductionMice, Inbred C57BLMyocardiumMetoprololAdrenergic beta-1 Receptor Antagonists

Author keywords

adrenergic signallingcachexiacardiac physiologydesensitizationheart ratepancreatic cancersympathetic nervous system

Substances

Receptors, Adrenergic, beta-1MetoprololAdrenergic beta-1 Receptor Antagonists

Authors and institutions

  • Medical Scientist Training Program, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon, USA.
  • Cancer Early Detection Advanced Research Center, Kight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
  • Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA.

ORCID profiles: Parham Diba, Samuel D Newton, Paige C Arneson-Wissink, Xinxia Zhu, Beth A Habecker, Daniel L Marks

Funding

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Heart, Lung, and Blood Institute of the National Institute of Health
  • National Cancer Institute of National Institute of Health
  • the Oregon Clinical and Translational Research Institute (OCTRI)
  • NIH HHS

Cite

APA

Diba, P., Levasseur, P. R., Newton, S. D., Koh, K. M. S., Arneson-Wissink, P. C., Zhu, X., Pham, P., Mendez, H., Whitcomb, L., Sattler, A., Woodward, W. R., Habecker, B. A., Marks, D. L., & Grossberg, A. J. (2026). Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart. The Journal of Physiology. https://doi.org/10.1113/jp290616

Vancouver

Diba P, Levasseur PR, Newton SD, Koh KMS, Arneson-Wissink PC, Zhu X, et al. Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart. The Journal of Physiology. 2026. doi:10.1113/jp290616

BibTeX
@article{Diba2026,
  author = {Diba, Parham and Levasseur, Peter R and Newton, Samuel D and Koh, Khia Min Sabrina and Arneson-Wissink, Paige C and Zhu, Xinxia and Pham, Peter and Mendez, Heike and Whitcomb, Luke and Sattler, Ariana and Woodward, William R and Habecker, Beth A and Marks, Daniel L and Grossberg, Aaron J},
  title = {Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart},
  journal = {The Journal of Physiology},
  year = {2026},
  doi = {10.1113/jp290616}
}
Start for free →